Summary Altra is a small cap company which does not fit my investor profile. Some readers, however, have requested I conduct the occasional review on small cap investment opportunities hence this analysis. Altra released its Q4 and FY2017 results on February 21, 2018 and within days it announced a proposal to amalgamate with 4 operating [...]
Summary WST has been in business for 95 years and has developed a strong reputation. The top 50 injectable biologics rely on WST and also supplies the top 75 pharmaceutical and biotech injectable companies. The company’s common stock cumulative total return has far exceeded the cumulative total return of the following Standard & Poor's (“S&P”) [...]
This is an introduction to my West Pharmaceutical stock analysis which is based on FY2017 results and FY2018 guidance provided by management. Introduction A reader recently inquired about my opinion on West Pharmaceutical Services, Inc. (NYSE: WST). This reader was of the opinion the stock might be a worthwhile addition to his portfolio because: the [...]
Many members of the younger generations are of the opinion US Social Security and the Canada Pension Plan and Old Age Security will not be around by the time they are eligible to collect. I am confident they will be around even though there are some minor imbalances. Even if these imbalances are not fixed, [...]
Summary This RPM stock analysis is based on Q3 2018 results released on April 5, 2018. RPM increased its dividend in October 2017 thus marking its 44th consecutive year of dividend increases. The dividend compound annual growth rate for the 2001 – 2018, however, is only ~5.7%. RPM’s returns since May 31, 2007 have outperformed [...]
North American equity markets are certainly experiencing some interesting times of late. Volatility has picked up and we are now experiencing triple digit intra-day swings in the S&P 500. Many investors who started investing subsequent to the Financial Crisis have never experienced this level of volatility. If you started investing subsequent to 2009, market conditions [...]
Another month has gone by and time for a very quick update on the FFJ Portfolio’s dividend income and changes I made to the FFJ Portfolio in March 2018. In the February 2018 report I reflected 400 Canadian National Railway (TSX: CNR) shares and 400 Walmart (NYSE: WMT) shares under investment account #6. These shares [...]
Market Volatility has certainly picked up recently. Look at the iPath S&P 500 VIX ST Futures ETN (VXX). Set the interval as weekly and look at different date ranges starting from the maximum date range and work your way down to the last 3 months. Note the spike commencing early February. The VXX is [...]
Summary Paychex reported strong Q3 results on March 26th and earlier in March it announced an acquisition in Germany which will offer PAYX the opportunity to expand its market penetration in Europe. The balance sheet is pristine and it continues to generate strong free cash flow. PAYX’s stock valuation has retraced from recent highs to [...]
In previous articles I have shared my opinion on Stock Picking Rules to Follow and The Basics of Investing. I have also shared with readers in a guest post why I think Chasing Yield is Fraught with Risk. In this post I share my reasons for choosing to have a long-term outlook when it comes [...]
